Genomed Spólka Akcyjna reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was PLN 4.69 million compared to PLN 4.75 million a year ago. Net income was PLN 0.066222 million compared to PLN 0.213946 million a year ago.
For the nine months, revenue was PLN 15.27 million compared to PLN 14.38 million a year ago. Net loss was PLN 0.386725 million compared to PLN 0.176808 million a year ago.